Banque Cantonale Vaudoise »

Bridgebio Pharma shares owned by Banque Cantonale Vaudoise

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Banque Cantonale Vaudoise from 13F filings

Historical chart of Banque Cantonale Vaudoise investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Banque Cantonale Vaudoise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Banque Cantonale Vaudoise

Quarter filed Position value Share count Share price at filing
2026-06-30 $186k 2.5k 74.40

More positions owned by Banque Cantonale Vaudoise

Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amrize SHS (AMRZ)
Caterpillar (CAT)
Cisco Systems (CSCO)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Coca-Cola Company (KO)
Astrazeneca Ord Add (AZN)
Eaton Corp SHS (ETN)
Bristol Myers Squibb (BMY)
Corning Incorporated (GLW)
Chubb (CB)
Cameco Corporation (CCJ)

View all positions for Banque Cantonale Vaudoise

Top funds holding Bridgebio Pharma

Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Wellington Management Company
State Street Corporation
Two Sigma Investments
Aisling Capital Management
Citadel Advisors

View all funds holding Bridgebio Pharma